triamcinolone acetonide
النصوص أدناه منقولة حرفياً وبلغتها الأصلية من نشرات الأدوية البيطرية المعتمدة لدى إدارة الغذاء والدواء الأمريكية (FDA) وقاعدة بيانات DailyMed.
دواعي الاستعمال (25)
Dogs (11)
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derma-Vet Cream
Otitis, cysts, and anal gland infections: Use petrolatum base ointment in dogs for the treatment of acute and chronic otitis and interdigital cysts, and in dogs for anal gland infections.
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Panolog® Ointment
The drug is recommended for use on dogs as an anti-inflammatory, antipruritic, and antiallergic agent for topical treatment of allergic dermatitis and summer eczema.
For use only by or on the order of a licensed veterinarian.
Vetalog Cream
Treatment of inflammation and related disorders in dogs; and management and treatment of acute arthritis and allergic and dermatologic disorders in dogs.
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
For infected anal glands and cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts, and for anal gland infections.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derma 4 Ointment
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
The drug is indicated for use in dogs for its anti-inflammatory activity.
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide
For topical treatment of allergic dermatitis and summer eczema in dogs.
VETAZINE
For the control of pruritus associated with allergic dermatitis.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For topical use in dogs only.
Genesis® Topical Spray
The drug is indicated for anti-inflammatory activity.
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog®
Cats (9)
For topical dermatological use. Use either ointment for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
Topically: Use either ointment in dogs and cats for anti-inflammatory, antipruritic, antifungal, and antibacterial treatment of superficial bacterial infections, and for dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly associated with bacterial or candidal (Candida albicans) infections.
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derma-Vet Cream
Treatment of inflammation and related disorders and management and treatment of acute arthritis and allergic and dermatologic disorders.
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide Suspension
Otitis and cysts: Use petrolatum base ointment in cats for the treatment of acute and chronic otitis and interdigital cysts.
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Panolog® Ointment
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts and for anal gland infections.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Animax® Ointment
For otic use. Use petrolatum base ointment for the treatment of acute and chronic otitis.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
For cystic areas. Use petrolatum base ointment for the treatment of interdigital cysts.
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian
Derm-Otic Ointment
The drug is indicated for use in cats for its anti-inflammatory activity.
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide
The drug is indicated for anti-inflammatory activity.
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog®
Horses (2)
Treatment of inflammation and related disorders in horses.
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
The drug is used as an anti-inflammatory agent.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.
Vetalog Oral Powder
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental da (1)
Treatment of inflammation and related disorders in cats; and management and treatment of acute arthritis and allergic and dermatologic disorders in cats.
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
دون تحديد نوع الحيوان (2)
Animax Ointment is particularly useful in the treatment of acute and chronic otitis of varied etiologies, in interdigital cysts in cats and dogs and in anal gland infections in dogs. The preparation is also indicated in the management of dermatologic disorders characterized by inflammation and dry or exudative dermatitis, particularly those caused, complicated, or threatened by bacterial or candidal (Candida albicans) infections. It is also of value in eczematous dermatitis, contact dermatitis, and seborrheic dermatitis; and as an adjunct in the treatment of dermatitis due to parasitic infestation.
Animax® Ointment (nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment)
GENESIS Topical Spray is indicated for the control of pruritus associated with allergic dermatitis in dogs.
Genesis Topical Spray
موانع الاستعمال (1)
دون تحديد نوع الحيوان (1)
Before instilling any medication into the ear, examine the external ear canal thoroughly to be certain the tympanic membrane is not ruptured in order to avoid the possibility of transmitting infection to the middle ear as well as damaging the cochlea or vestibular apparatus from prolonged contact. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue the use of Animax Ointment.
Animax® Ointment (nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment)
التحذيرات (2)
دون تحديد نوع الحيوان (2)
User Safety: Wear gloves when applying the product. Spray in a well ventilated area. If the spray causes irritation to mucous membranes, discontinue use. Keep this and all drugs out of reach of children. Animal Safety: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palates in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia, and anasarca.
Genesis Topical Spray
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in the offspring. In dogs, other congenital anomalies have resulted: deformed forelegs, phocomelia, and anasarca. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Animax® Ointment (nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment)
الآثار الجانبية (2)
دون تحديد نوع الحيوان (2)
SAP and SGPT (ALT) enzyme elevations, polydipsia and polyuria, vomiting, and diarrhea (occasionally bloody) have been observed following parenteral or systemic use of synthetic corticosteroids in dogs. Cushing's syndrome has been reported in association with prolonged or repeated steroid therapy in dogs. Temporary hearing loss has been reported in conjunction with treatment of otitis with products containing corticosteroids. However, regression usually occurred following withdrawal of the drug. Hearing loss, with varying degrees of recovery, has been reported with the use of Animax Ointment. If hearing dysfunction is noted during the course of treatment with Animax Ointment, discontinue its use. To report suspected adverse drug events, for technical assistance or to obtain a copy of the safety data sheet (SDS), contact Dechra at (866) 933-2472. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.fda.gov/reportanimalae.
Animax® Ointment (nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment)
In a field study with GENESIS Topical Spray, polyuria was reported in 3 of 57 dogs (5.3%) and polyphagia in 1 of 57 dogs (1.8%). Mild (within reference range) decreases in total leukocyte, lymphocyte and eosinophil counts were also reported. The following local reactions were reported in ≤ 3.6% of 110 dogs treated with GENESIS Topical Spray or the product vehicle: aversion/discomfort, sneezing and watery eyes.
Genesis Topical Spray
الجرعات (28)
Dogs (13)
Single injection of 0.05 to 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Or administer 1.2 to 1.8 milligrams intralesionally, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams intralesionally and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams intralesionally. Or administer a single injection of 1 to 3 milligrams intra-articularly and intrasynovially, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams intra-articularly and intrasynovially.
Intramuscular, Intra-Articular, Intrasynovial, Subcutaneous, Intralesional
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide Suspension
Intramuscular or subcutaneous: Single injection of 0.05 to 0.1 milligram per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligram per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Intralesional: 1.2 to 1.8 milligrams, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams. Intra-articular and intrasynovial: Single injection of 1 to 3 milligram dose, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams.
Intramuscular, Intralesional, Intra-Articular, Subcutaneous, Intrasynovial
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day. Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear.
Oral
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day.
Oral
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog®
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For infected anal glands and cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Topical
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Panolog® Ointment
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
Apply sufficient pump sprays to uniformly and thoroughly wet the affected areas while avoiding run off of excess product. Administer twice daily for 7 days, then once daily for 7 days, then every other day for an additional 14 days (28 days total).
Topical
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For topical use in dogs only.
Genesis® Topical Spray
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Animax® Ointment
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Topical
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derma-Vet Cream
The drug is applied by rubbing into affected areas two to four times daily for 4 to 10 days.
Topical
For use only by or on the order of a licensed veterinarian.
Vetalog Cream
Apply by rubbing into the affected areas two to four times daily for 4 to 10 days.
Topical
VETAZINE
Cats (9)
Single injection of 0.05 to 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligrams intramuscularly or subcutaneously per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Or administer 1.2 to 1.8 milligrams intralesionally, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams intralesionally and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams intralesionally. Or administer a single injection of 1 to 3 milligrams intra-articularly and intrasynovially, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams intra-articularly and intrasynovially.
Intramuscular, Intra-Articular, Intrasynovial, Subcutaneous, Intralesional
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide Suspension
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day. Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear.
Oral
The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide
An initial daily dosage of 0.05 milligram per pound of body weight is usually sufficient to control symptoms, although up to 0.1 milligram per pound of body weight may be given daily if response to the smaller dose is inadequate. As soon as feasible, and in any case within 2 weeks, dosage should be reduced gradually to maintenance levels of 0.0125 to 0.025 milligram per pound of body weight per day.
Oral
Therapy should be discontinued by a gradual reduction in dosage after the condition has been controlled for several days. Therapy may be initiated with a single dose of sterile triamcinolone acetonide suspension veterinary in which case the tablet dosage should be administered beginning 5 to 7 days after the injection or when symptoms reappear. The labeling shall comply with the requirements of 510.410 of this chapter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog®
Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
For otic use: Clean ear canal of impacted cerumen, remove any foreign bodies such as grass awns and ticks, and instill three to five drops of petrolatum base ointment. Preliminary use of a local anesthetic may be advisable. For cystic areas: Drain gland or cyst and fill with petrolatum base ointment.
Topical
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Panolog® Ointment
Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derm-Otic Ointment
For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Animax® Ointment
Drain gland or cyst and fill with petrolatum base ointment. For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs.
Topical
Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
DERMA-VET® Ointment
For topical dermatological use: Clean affected areas and remove any encrusted discharge or exudate, and apply sparingly either ointment in a thin film.
Topical
For mild inflammations, use once daily to once a week. For severe conditions, apply initially two to three times daily, decreasing frequency as improvement occurs. Not intended for treatment of deep abscesses or deep-seated infections. Not for ophthalmic use. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Derma-Vet Cream
Horses (3)
Single injection of 0.01 to 0.02 milligrams intramuscularly or subcutaneously per pound of body weight. Usual dose, 12 to 20 milligrams intramuscularly or subcutaneously. Or administer single injection of 6 to 18 milligrams intra-articularly and intrasynovially dose dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage may be increased not to exceed 18 milligrams intra-articularly and intrasynovially.
Intramuscular, Intra-Articular, Intrasynovial, Subcutaneous, Intralesional
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Not for use in horses intended for food. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Triamcinolone Acetonide Suspension
Intramuscular or subcutaneous: Single injection of 0.01 to 0.02 milligrams per pound of body weight. Usual dose, 12 to 20 milligrams. Intra-articular and intrasynovial: Single injection of 6 to 18 milligram dose dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage may be increased not to exceed 18 milligrams.
Intramuscular, Intralesional, Intra-Articular, Subcutaneous, Intrasynovial
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Do not use in the treatment of laminitis. Intra-articular injection in equine leg injuries may produce osseous metaplasia. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
It is administered at a dosage of 0.005 to 0.01 milligram triamcinolone acetonide per pound of body weight twice daily, sprinkled (top-dressed) on a small portion of feed. Treatment may be initiated with a single dose of sterile triamcinolone acetonide suspension USP followed after 3 or 4 days with the use of triamcinolone acetonide oral powder.
Oral
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.
Vetalog Oral Powder
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental da (1)
Intramuscular or subcutaneous: Single injection of 0.05 to 0.1 milligram per pound of body weight in inflammatory, arthritic or allergic disorders. Single injection of 0.1 milligram per pound of body weight in dermatologic disorders. If symptoms recur the dose may be repeated, or oral corticosteroid therapy may be instituted. Intralesional: 1.2 to 1.8 milligrams, divided in several injections, spaced around the lesion at 0.5 to 2.5 centimeters apart depending on the size. At any one site the dose injected should not exceed 0.6 milligrams and should be well into the cutis to prevent rupture of the epidermis. When treating animals with multiple lesions, do not exceed a total dose of 6 milligrams. Intra-articular and intrasynovial: Single injection of 1 to 3 milligram dose, dependent on size of joint and severity of symptoms. After 3 or 4 days, repeat dosage if indicated. If initial results are inadequate or too transient, dosage exceed 3 milligrams.
Intramuscular, Intralesional, Intra-Articular, Subcutaneous, Intrasynovial
Do not use in viral infections. With bacterial infections appropriate antibacterial therapy should be used. Do not use in animals with tuberculosis, chronic nephritis or cushingoid syndrome, except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Vetalog® Parenteral
دون تحديد نوع الحيوان (2)
Frequency of administration is dependent on the severity of the condition. For mild inflammations, application may range from once daily to once a week; for severe conditions Animax Ointment may be applied as often as two to three times daily, if necessary. Frequency of treatment may be decreased as improvement occurs. Wear gloves during the administration of the ointment or wash hands immediately after application. Otitis Clean ear canal of impacted cerumen. Inspect canal and remove any foreign bodies such as grass awns, ticks, etc. Instill three to five drops of Animax Ointment. Preliminary use of a local anesthetic may be advisable. Infected Anal Glands, Cystic Areas, etc. Drain gland or cyst and then fill with Animax Ointment. Other Dermatologic Disorders Clean affected areas, removing any encrusted discharge or exudate. Apply Animax Ointment sparingly in a thin film.
TOPICAL, AURICULAR (OTIC)
Animax® Ointment (nystatin-neomycin sulfate-thiostrepton-triamcinolone acetonide ointment)
Apply suffcient pump sprays to uniformly and thoroughly wet the affected areas while avoiding run-off of excess product. Avoid getting the spray in dog’s eyes. GENESIS Topical Sprays should be administered twice daily for seven days, once daily for the next seven days, then every other day for an additional 14 days (28 days total). To avoid overdosing the product, use the following table to determine the maximum number of pump sprays per treatment application. For mild pruritus or for small treatment surface areas, the number of pumps used should be less than this maximum amount.
TOPICAL
Genesis Topical Spray
التراكيز المتوفرة (32)
| المنتج | الشكل الصيدلاني | التراكيز المتوفرة |
|---|---|---|
| Derma-Vet Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Derma-Vet Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Animax® Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Animax® Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Genesis® Topical Spray | Liquid (Solution) | Each milliliter of solution contains 0.15 milligrams (0.015%) triamcinolone acetonide. |
| Vetalog® Parenteral | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Vetalog® Parenteral | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Vetalog® Parenteral | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Panolog® Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Panolog® Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Vetalog Cream | Cream | Triamcinolone acetonide cream contains 0.1 percent triamcinolone acetonide in an aqueous vanishing cream base. |
| Medalone Cream | Cream | Triamcinolone acetonide cream contains 0.1 percent triamcinolone acetonide in an aqueous vanishing cream base. |
| Derm-Otic Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Derm-Otic Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Derma 4 Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Derma 4 Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| DERMA-VET® Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| DERMA-VET® Ointment | Ointment | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Triamcinolone Acetonide Suspension | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Triamcinolone Acetonide Suspension | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Triamcinolone Acetonide Suspension | Liquid (Suspension) | Each milliliter of suspension contains 2 or 6 milligrams triamcinolone acetonide. |
| Triamcinolone Acetonide | Tablet | Each tablet contains 0.5 and 1.5 milligrams of the drug. |
| Triamcinolone Acetonide | Tablet | Each tablet contains 0.5 and 1.5 milligrams of the drug. |
| Vetalog Oral Powder | Powder | Each 15 grams of triamcinolone acetonide oral powder contains 10 milligrams of triamcinolone acetonide. |
| Animax® Ointment | Ointment | Each milliliter contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Animax® Ointment | Ointment | Each milliliter contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Vetalog® | Tablet | Each tablet contains 0.5 and 1.5 milligrams of the drug. |
| Vetalog® | Tablet | Each tablet contains 0.5 and 1.5 milligrams of the drug. |
| Panolog® Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| Panolog® Cream | Cream | Each milliliter of petrolatum base or each gram of vanishing cream base ointment contains: 100,000 units of nystatin; neomycin sulfate equivalent to 2.5 milligrams of neomycin base; 2,500 units of thiostrepton; and 1.0 milligram of triamcinolone acetonide. |
| VETAZINE | Cream | 1 mg of triamcinolone acetonide per gram |
| — | — | 0.15 mg / 1 mL |